Plain-English translation of NCT06567782 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether , a new type of immunotherapy medication, works better when combined with standard chemotherapy (called ) to treat advanced colon cancer. You would receive this combination before surgery to remove your tumor. The study will compare people who get both the medication and chemotherapy against people who receive chemotherapy alone, to see which approach is more effective.
Most colon cancers don't respond well to immunotherapy alone, but researchers believe combining this medication with chemotherapy might improve results. This study aims to find out whether this new treatment approach can help more patients with this specific type of colon cancer.
You likely qualify if…
You likely don't qualify if…
If you qualify and are randomized, you'll be assigned to receive either the new medication plus chemotherapy or chemotherapy alone, given before your planned surgery. You'll attend regular clinic visits for treatment infusions and blood tests to monitor how your body is responding. After completing the treatment period, you'll have surgery to remove your tumor, and the research team will examine tissue samples to evaluate how well the treatment worked.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Belgium